Abstract
Rapid estrogen actions are triggered after estrogens are bound to a variety of proteins in organelles other than the nucleus. Those include classic estrogen receptors ERα and ERβ, novel membrane proteins that behave as estrogen receptors such as GPR30, ion channels, and other ligand receptors. In pancreatic α and β-cells, estrogens binding to a non-classical membrane estrogen receptors at physiological concentrations regulate ion channels and [Ca2+]i signals, provoking important physiological responses. In β-cells, 17β- estradiol regulates KATP channel activity and glucose-induced [Ca2+]i oscillations, eliciting changes in insulin release and the activation of Ca2+-dependent transcription factors. In α-cells, 17β-estradiol abolishes low glucose-induced [Ca2+]i oscillations.
Infectious Disorders - Drug Targets
Title: Rapid Regulation of Pancreatic α- and β- Cell Signalling Systems by Estrogens
Volume: 8 Issue: 1
Author(s): Cristina Ripoll, Ana B. Ropero, Paloma Alonso-Magdalena, Ivan Quesada, Esther Fuentes and Angel Nadal
Affiliation:
Abstract: Rapid estrogen actions are triggered after estrogens are bound to a variety of proteins in organelles other than the nucleus. Those include classic estrogen receptors ERα and ERβ, novel membrane proteins that behave as estrogen receptors such as GPR30, ion channels, and other ligand receptors. In pancreatic α and β-cells, estrogens binding to a non-classical membrane estrogen receptors at physiological concentrations regulate ion channels and [Ca2+]i signals, provoking important physiological responses. In β-cells, 17β- estradiol regulates KATP channel activity and glucose-induced [Ca2+]i oscillations, eliciting changes in insulin release and the activation of Ca2+-dependent transcription factors. In α-cells, 17β-estradiol abolishes low glucose-induced [Ca2+]i oscillations.
Export Options
About this article
Cite this article as:
Ripoll Cristina, Ropero B. Ana, Alonso-Magdalena Paloma, Quesada Ivan, Fuentes Esther and Nadal Angel, Rapid Regulation of Pancreatic α- and β- Cell Signalling Systems by Estrogens, Infectious Disorders - Drug Targets 2008; 8 (1) . https://dx.doi.org/10.2174/187152608784139668
DOI https://dx.doi.org/10.2174/187152608784139668 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial (Hot Topic: Update on Treatment Strategies in Patients with Non-alcoholic Fatty Liver Disease)
Current Pharmaceutical Design Anti-Inflammatory Iridoids of Botanical Origin
Current Medicinal Chemistry A Systematic, Updated Review on the Antidepressant Agomelatine Focusing on its Melatonergic Modulation
Current Neuropharmacology Immune Mechanism, Aging, Season and Diseases: Modulatory Role of Melatonin
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Imatinib Mesylate for the Treatment of Solid Tumours: Recent Trials and Future Directions
Current Enzyme Inhibition Roles of Retinoic Acid in Induction of Immunity and Immune Tolerance
Endocrine, Metabolic & Immune Disorders - Drug Targets The Critical Role of Vascular Endothelial Growth Factor in Tumor Angiogenesis
Current Cancer Drug Targets S100A9 as a Pharmacological Target Molecule in Inflammation and Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Flaxseed and Diabetes
Current Pharmaceutical Design Microfluidic Control of Hypoxia Aids Investigations of Islet Pathophysiology
Micro and Nanosystems Multiple Roles of Fibroblast Growth Factor 21 in Metabolism
Current Pharmaceutical Design Particle Design of Membrane Emulsification for Protein Drug and Vaccine Delivery
Current Pharmaceutical Design Metaboloepigenetics: The Emerging Network in Stem Cell Homeostasis Regulation
Current Stem Cell Research & Therapy Phytogenic Polyphenols as Glycogen Phosphorylase Inhibitors: The Potential of Triterpenes and Flavonoids for Glycaemic Control in Type 2 Diabetes
Current Medicinal Chemistry GLP - 1 Analogs: Newer Molecules, Newer Uses
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Natural Products Targeting EGFR Signaling Pathways as Potential Anticancer Drugs
Current Protein & Peptide Science Development and Characterization of Spray Dried Microparticles for Pulmonary Delivery of Antifungal Drug
Current Drug Delivery Subclinical Thyroid Dysfunction and Cardiovascular Outcomes among Prospective Cohort Studies
Endocrine, Metabolic & Immune Disorders - Drug Targets Extracellular Hsp70: Export and Function
Current Protein & Peptide Science Treatment of Chronic Peripheral Arterial Disease
Current Vascular Pharmacology